학술논문
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Original Article
Original Article
Document Type
Report
Author
Motzer, Robert; Alekseev, Boris; Rha, Sun-Young; Porta, Camillo; Eto, Masatoshi; Powles, Thomas; Grunwald, Viktor; Hutson, Thomas E.; Kopyltsov, Evgeny; Mendez-Vidal, María J.; Kozlov, Vadim; Alyasova, Anna; Hong, Sung-Hoo; Kapoor, Anil; Alonso Gordoa, Teresa; Merchan, Jaime R.; Winquist, Eric; Maroto, Pablo; Goh, Jeffrey C.; Kim, Miso; Gurney, Howard; Patel, Vijay; Peer, Avivit; Procopio, Giuseppe; Takagi, Toshio; Melichar, Bohuslav; Rolland, Frederic; De Giorgi, Ugo; Wong, Shirley; Bedke, Jens; Schmidinger, Manuela; Dutcus, Corina E.; Smith, Alan D.; Dutta, Lea; Mody, Kalgi; Perini, Rodolfo F.; Xing, Dongyuan; Choueiri, Toni K.
Source
The New England Journal of Medicine. April 8, 2021, Vol. 384 Issue 14, p1289, 12 p.
Subject
Language
English
ISSN
0028-4793